Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis

J Clin Oncol. 2011 Aug 1;29(22):e650-2. doi: 10.1200/JCO.2011.34.8367. Epub 2011 May 31.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Amputation, Surgical
  • Antibodies, Monoclonal / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / surgery
  • Chemotherapy, Adjuvant
  • Cisplatin / administration & dosage
  • Docetaxel
  • Drug Administration Schedule
  • ErbB Receptors / antagonists & inhibitors*
  • Fluorouracil / administration & dosage
  • Humans
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Molecular Targeted Therapy*
  • Neoplasm Recurrence, Local / diagnosis
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / metabolism
  • Neoplasm Staging
  • Panitumumab
  • Penile Neoplasms / diagnosis
  • Penile Neoplasms / drug therapy*
  • Penile Neoplasms / metabolism
  • Penile Neoplasms / surgery
  • Positron-Emission Tomography
  • Sentinel Lymph Node Biopsy
  • Taxoids / administration & dosage
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Taxoids
  • Docetaxel
  • Panitumumab
  • ErbB Receptors
  • Cisplatin
  • Fluorouracil